BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28532265)

  • 1. Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience.
    Winstead M; Sun PP; Martin K; Earl J; Neumayr L; Hoppe C; Vichinsky E
    Pediatr Hematol Oncol; 2017 Mar; 34(2):100-106. PubMed ID: 28532265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of surgical revascularization for stroke prevention in pediatric patients with sickle cell disease and moyamoya syndrome.
    Yang W; Xu R; Porras JL; Takemoto CM; Khalid S; Garzon-Muvdi T; Caplan JM; Colby GP; Coon AL; Tamargo RJ; Huang J; Ahn ES
    J Neurosurg Pediatr; 2017 Sep; 20(3):232-238. PubMed ID: 28686127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure.
    Fryer RH; Anderson RC; Chiriboga CA; Feldstein NA
    Pediatr Neurol; 2003 Aug; 29(2):124-30. PubMed ID: 14580655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encephaloduroateriosynangiosis (EDAS) in the management of Moyamoya syndrome in children with sickle cell disease.
    Alamri A; Hever P; Cheserem J; Gradil C; Bassi S; Tolias CM
    Br J Neurosurg; 2019 Apr; 33(2):161-164. PubMed ID: 28616936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review.
    Aguilar-Salinas P; Hayward K; Santos R; Agarwal V; Sauvageau E; Hanel RA; Aldana PR
    World Neurosurg; 2019 Mar; 123():435-442.e8. PubMed ID: 30496928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.
    Zhang Y; Bao XY; Duan L; Yang WZ; Li DS; Zhang ZS; Han C; Zhao F; Zhang Q; Wang QN
    J Neurosurg Pediatr; 2018 Aug; 22(2):173-180. PubMed ID: 29856299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.
    Agarwalla PK; Stapleton CJ; Phillips MT; Walcott BP; Venteicher AS; Ogilvy CS
    J Neurosurg; 2014 Dec; 121(6):1394-400. PubMed ID: 25280094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of infarction after encephaloduroarteriosynangiosis in young patients with moyamoya disease.
    Kim HG; Lee SK; Lee JD
    J Neurosurg Pediatr; 2017 Jan; 19(1):1-7. PubMed ID: 27715484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Encephaloduroarteriosynangiosis with Dural Inversion for Moyamoya Disease in a Pediatric and Adult Population-a Single-Center 20-Year Experience.
    Goren O; Hendrix P; Peled A; Kimchi G; Zauberman J; Griessenauer C; Feldman Z
    World Neurosurg; 2021 May; 149():e16-e21. PubMed ID: 33647488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of encephalo-myo-synangiosis in surgical revascularization strategies for moyamoya disease in children and adults.
    Imai H; Miyawaki S; Ono H; Nakatomi H; Yoshimoto Y; Saito N
    World Neurosurg; 2015 May; 83(5):691-9. PubMed ID: 25655688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.
    Pandey P; Steinberg GK
    J Neurosurg; 2011 Aug; 115(2):328-36. PubMed ID: 21529138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical treatment of moyamoya disease in children: which is more effective procedure, EDAS or EMS?
    Fujita K; Tamaki N; Matsumoto S
    Childs Nerv Syst; 1986; 2(3):134-8. PubMed ID: 3779669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of the Arachnoid Membrane During Encephaloduroarteriosynangiosis Reduces Postoperative Complications without Undermining the Surgical Outcome in Pediatric Moyamoya Disease.
    Byun YH; Phi JH; Lee JY; Ha EJ; Kim KH; Yang J; Kim HS; Ryu SK; Choi JW; Cho BK; Kim SK
    World Neurosurg; 2019 Oct; 130():e406-e416. PubMed ID: 31233923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encephaloduroarteriosynangiosis (EDAS) for the treatment of childhood moyamoya disease.
    Ross IB; Shevell MI; Montes JL; Rosenblatt B; Watters GV; Farmer JP; O'Gorman AM
    Pediatr Neurol; 1994 May; 10(3):199-204. PubMed ID: 8060421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease.
    Vernet O; Montes JL; O'Gorman AM; Baruchel S; Farmer JP
    Pediatr Neurol; 1996 Apr; 14(3):226-30. PubMed ID: 8736407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encephaloduroarteriosynangiosis for adult intracranial arterial steno-occlusive disease: long-term single-center experience with 107 operations.
    Gonzalez NR; Dusick JR; Connolly M; Bounni F; Martin NA; Van de Wiele B; Liebeskind DS; Saver JL
    J Neurosurg; 2015 Sep; 123(3):654-61. PubMed ID: 26067617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease.
    Terrell D; Savardekar AR; Whipple SG; Dossani RH; Spetzler RF; Sun H
    World Neurosurg; 2020 May; 137():62-70. PubMed ID: 32014541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.